Evidence map›Paper›PMID 36079081›Full record

ReviewJournal of clinical medicine2022

(R)Evolution in Allergic Rhinitis Add-On Therapy: From Probiotics to Postbiotics and Parabiotics.

Martina Capponi, Alessandra Gori, Giovanna De Castro, Giorgio Ciprandi, Caterina Anania, Giulia Brindisi, Mariangela Tosca, Bianca Laura Cinicola, Alessandra Salvatori, Lorenzo Loffredo and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Martina CapponiDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Alessandra GoriDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Giovanna De CastroDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Giorgio CiprandiAllergy Clinic, Casa di Cura Villa Serena, 65013 Genoa, Italy.ORCID 0000-0001-7016-8421
Caterina AnaniaDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Giulia BrindisiDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-5059-6082
Mariangela ToscaAllergy Center, IRCCCS Ist. Giannina Gaslini, 65013 Genoa, Italy.
Bianca Laura CinicolaDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-1268-5038
Alessandra SalvatoriDepartment of Woman and Child of General and Specialistic Surgery, University of Campania "Luigi Vanvitelli", 80138 Napoli, Italy.ORCID 0000-0002-6289-2249
Lorenzo LoffredoDepartment of Internal Medicine and Medical Specialties, Sapienza University, 00185 Rome, Italy.ORCID 0000-0002-6542-6235
Alberto SpaliceChild Neurology Division, Department of Pediatrics, Sapienza University of Rome, 00185 Rome, Italy.
Anna Maria ZicariDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Sapienza University of Rome · ITCasa di Cura Villa Garda · ITIstituto Giannina Gaslini · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Starting from the "Hygiene Hypothesis" to the "Microflora hypothesis" we provided an overview of the symbiotic and dynamic equilibrium between microbiota and the immune system, focusing on the role of dysbiosis in atopic march, particularly on allergic rhinitis. The advent of deep sequencing technologies and metabolomics allowed us to better characterize the microbiota diversity between individuals and body sites. Each body site, with its own specific environmental niches, shapes the microbiota conditioning colonization and its metabolic functionalities. The analysis of the metabolic pathways provides a mechanistic explanation of the remote mode of communication with systems, organs, and microflora of other body sites, including the ecosystem of the upper respiratory tract. This axis may have a role in the development of respiratory allergic disease. Notably, the microbiota is significant in the development and maintenance of barrier function; influences hematopoiesis and innate immunity; and shows its critical roles in Th1, Th2, and Treg production, which are necessary to maintain immunological balance and promote tolerance, taking part in every single step of the inflammatory cascade. These are microbial biotherapy foundations, starting from probiotics up to postbiotics and parabiotics, in a still-ongoing process. When considering the various determinants that can shape microbiota, there are several factors to consider: genetic factors, environment, mode of delivery, exposure to antibiotics, and other allergy-unrelated diseases. These factors hinder the engraftment of probiotic strains but may be upgradable with postbiotic and parabiotic administration directly on molecular targets. Supplementation with postbiotics and parabiotics could represent a very exciting perspective of treatment, bypassing probiotic limitations. At present, this avenue remains theoretical and to be explored, but it will certainly be a fascinating path to follow.

Indexed as

allergic diseaseallergic inflammationallergic rhinitisatopic marchimmune systemmicrobiotaparabioticpostbioticsprobiotics

Identifiers

PMID36079081
PMCPMC9456659
OpenAlexW4294308428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.